When will the Riboflavin 5-phosphate Ophthalmic Solution shortage end?

FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.

Does FDA list alternatives to Riboflavin 5-phosphate Ophthalmic Solution?

No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.

Is Riboflavin 5-phosphate Ophthalmic Solution being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Riboflavin 5-phosphat…: 1 maker discontinuing

Eye drops

A generic eye drops, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.

DRUG

Riboflavin 5-phosphate Ophthalmic Solution

FDA LISTING

Riboflavin 5-phosphate Ophthalmic Solution

FORM

eye drops

STATUS

Discontinuation

FIRST POSTED

Jan 20, 2026

LAST FDA UPDATE

Jan 20, 2026

AS OF

Oct 24, 2026

SOURCE

FDA Drug Shortages ↗ (opens in a new tab)

1 discontinuation notice below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Riboflavin 5-phosphate Ophthalmic Solution. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
Is my strength or the maker you stock affected? FDA list, by presentation
Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

Glaukos Corporation told FDA it will discontinue Photrexa Cross-linking Kit (posted Jan 20, 2026).
“Discontinuing manufacture of the product as of July 2026.”
FDA listing: Riboflavin 5-phosphate Ophthalmic Solution

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Riboflavin 5-phosphate Ophthalmic Solution being discontinued?: As of Oct 24, 2026, FDA lists discontinuation notices for Riboflavin 5-phosphate Ophthalmic Solution, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Riboflavin 5-phosphate Ophthalmic Solution shortage end?: FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Riboflavin 5-phosphate Ophthalmic Solution?: No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.